دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Migrant health: a global responsibility
doi : 10.1016/S2213-8587(22)00359-X
Volume 11, Issue 1, January 2023, Page 1
Long-term bone health in childhood cancer survivors: underappreciated and undertreated?
Cornelia S Link-Rachner a c, Tilman D Rachner b d
Predicting the response to GLP-1 receptor agonists: an unexpected role for β-arrestin-1
doi : 10.1016/S2213-8587(22)00357-6
Volume 11, Issue 1, January 2023, Pages 3-4
Re-evaluating obesity in Mexico—lessons for the global obesity epidemic
doi : 10.1016/S2213-8587(22)00348-5
Volume 11, Issue 1, January 2023, Pages 5-6
The role of nurses in diabetes care: challenges and opportunities
doi : 10.1016/S2213-8587(22)00314-X
Volume 11, Issue 1, January 2023, Pages 6-8
An inclusive approach to people with disabilities in diabetes care and education
doi : 10.1016/S2213-8587(22)00343-6
Volume 11, Issue 1, January 2023, Pages 8-10
Diabetes after SARS-CoV-2 infection
doi : 10.1016/S2213-8587(22)00324-2
Volume 11, Issue 1, January 2023, Pages 11-13
Mendelian randomisation and vitamin D: the importance of model assumptions
doi : 10.1016/S2213-8587(22)00345-X
Volume 11, Issue 1, January 2023, Page 14
Mendelian randomisation and vitamin D: the importance of model assumptions
doi : 10.1016/S2213-8587(22)00342-4
Volume 11, Issue 1, January 2023, Pages 14-15
Mendelian randomisation and vitamin D: the importance of model assumptions – Authors' reply
doi : 10.1016/S2213-8587(22)00344-8
Volume 11, Issue 1, January 2023, Pages 15-16
Silver Bahendeka: the obligation to hope
doi : 10.1016/S2213-8587(22)00356-4
Volume 11, Issue 1, January 2023, Page 17
FDA approves teplizumab: a milestone in type 1 diabetes
doi : 10.1016/S2213-8587(22)00351-5
Volume 11, Issue 1, January 2023, Page 18
Osteoporosis in the USA: prevention and unmet needs
doi : 10.1016/S2213-8587(22)00322-9
Volume 11, Issue 1, January 2023, Pages 19-20
Correction to Lancet Diabetes Endocrinol 2022; 10: 489–98
doi : 10.1016/S2213-8587(22)00347-3
Volume 11, Issue 1, January 2023, Page e1
Correction to Lancet Diabetes Endocrinol 2021; 9: 575–85
doi : 10.1016/S2213-8587(22)00350-3
Volume 11, Issue 1, January 2023, Page e1
Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study
Jenneke E van Atteveld MD a *, Demi T C de Winter MD a *, Vincent G Pluimakers MD a, Prof Marta Fiocco PhD a b e, Prof Rutger A J Nievelstein MD a f, Monique G G Hobbelink MD f, Andrica C H de Vries MD a h, Jacqueline J Loonen MD i, Eline van Dulmen-den Broeder PhD j, Helena J van der Pal MD a, Saskia M F Pluijm PhD a, Prof Leontien C M Kremer PhD a j l, Cécile M Ronckers PhD a, Margriet van der Heiden-van der Loo PhD a m, A Birgitta Versluijs MD a, Marloes Louwerens MD c, Dorine Bresters MD a d, Hanneke M van Santen MD a k, Daniel S Olsson MD n, Imo Hoefer MD g…Prof Marry M van den Heuvel-Eibrink MD a h l â€
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
doi : 10.1016/S2213-8587(22)00340-0
Volume 11, Issue 1, January 2023, Pages 33-41
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
doi : 10.1016/S2213-8587(22)00319-9
Volume 11, Issue 1, January 2023, Pages 42-57
Treating chronic diseases without tackling excess adiposity promotes multimorbidity
Prof Naveed Sattar FMedSci a, Prof John J V McMurray MD a, Prof Iain B McInnes PhD b, Vanita R Aroda MD c, Prof Mike E J Lean MD d
